JP2023171659A5 - - Google Patents

Download PDF

Info

Publication number
JP2023171659A5
JP2023171659A5 JP2023177565A JP2023177565A JP2023171659A5 JP 2023171659 A5 JP2023171659 A5 JP 2023171659A5 JP 2023177565 A JP2023177565 A JP 2023177565A JP 2023177565 A JP2023177565 A JP 2023177565A JP 2023171659 A5 JP2023171659 A5 JP 2023171659A5
Authority
JP
Japan
Prior art keywords
formula
alkyl
group
hydrogen
represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023177565A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023171659A (ja
Filing date
Publication date
Priority claimed from PCT/KR2021/003807 external-priority patent/WO2021194318A1/en
Application filed filed Critical
Publication of JP2023171659A publication Critical patent/JP2023171659A/ja
Publication of JP2023171659A5 publication Critical patent/JP2023171659A5/ja
Pending legal-status Critical Current

Links

JP2023177565A 2020-03-27 2023-10-13 Plk1の選択的分解誘導化合物 Pending JP2023171659A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR10-2020-0037875 2020-03-27
KR20200037875 2020-03-27
PCT/KR2021/003807 WO2021194318A1 (en) 2020-03-27 2021-03-27 Plk1 selective degradation inducing compound
JP2021578216A JP7440940B2 (ja) 2020-03-27 2021-03-27 Plk1の選択的分解誘導化合物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021578216A Division JP7440940B2 (ja) 2020-03-27 2021-03-27 Plk1の選択的分解誘導化合物

Publications (2)

Publication Number Publication Date
JP2023171659A JP2023171659A (ja) 2023-12-01
JP2023171659A5 true JP2023171659A5 (https=) 2024-04-10

Family

ID=77892014

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021578216A Active JP7440940B2 (ja) 2020-03-27 2021-03-27 Plk1の選択的分解誘導化合物
JP2023177565A Pending JP2023171659A (ja) 2020-03-27 2023-10-13 Plk1の選択的分解誘導化合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021578216A Active JP7440940B2 (ja) 2020-03-27 2021-03-27 Plk1の選択的分解誘導化合物

Country Status (6)

Country Link
US (5) US20230158158A1 (https=)
EP (1) EP3911654A4 (https=)
JP (2) JP7440940B2 (https=)
KR (8) KR20210122165A (https=)
CN (1) CN113784969A (https=)
WO (4) WO2021194318A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020356484A1 (en) * 2019-09-27 2022-03-17 Dana-Farber Cancer Institute, Inc. ERK5 degraders as therapeutics in cancer and inflammatory diseases
US20230158158A1 (en) * 2020-03-27 2023-05-25 Uppthera Pyrazolo quinazoline derivative compounds inducing selective degradation of plk1
KR20240035820A (ko) 2021-07-09 2024-03-18 플렉시움 인코포레이티드 Ikzf2를 조절하는 아릴 화합물 및 약학 조성물
EP4157849A4 (en) * 2021-08-10 2024-12-11 Uppthera, Inc. NOVEL PLK1 DEGRADATION-INDUCING COMPOUND
US20250171417A1 (en) 2021-08-11 2025-05-29 Xizang Haisco Pharmaceutical Co., Ltd. Heterocyclic derivative, and composition and pharmaceutical use thereof
CN114380682A (zh) * 2021-10-27 2022-04-22 上海毕得医药科技股份有限公司 一种2,3-二氟-4-甲氧基苯乙酸合成方法
CN118339161B (zh) * 2021-12-10 2025-12-09 正大天晴药业集团股份有限公司 一种异噻唑并[5,4-d]嘧啶类IRAK4抑制剂的制备方法
CN118382626A (zh) * 2021-12-10 2024-07-23 山东绿叶制药有限公司 蛋白激酶抑制剂及其制备方法和应用
CN116924929A (zh) * 2022-07-08 2023-10-24 重庆圣华曦药业股份有限公司 一种碘比醇异构体的合成方法
CN115490675B (zh) * 2022-09-19 2024-11-12 安阳师范学院 季酮酸衍生物及其制备方法与应用
CN120603831A (zh) * 2022-11-29 2025-09-05 厄普特拉株式会社 具有增加的刚性的plk1降解诱导化合物
CN120530121A (zh) * 2023-01-17 2025-08-22 北京哲源科技有限责任公司 吡唑并喹唑啉类化合物的立体异构体和氘代衍生物及应用
KR20250037591A (ko) * 2023-02-02 2025-03-17 (주) 업테라 신규 plk1 분해 유도 화합물
CN116554044A (zh) * 2023-05-16 2023-08-08 上海师范大学 一种无氨基保护的2,6-二异丙基-4-羧基苯胺及其合成方法
KR20250058831A (ko) 2023-10-23 2025-05-02 주식회사 펩토이드 Plk-1의 폴로박스 도메인에 결합하는 저분자 화합물을 함유하는 항암제
WO2025239662A1 (ko) * 2024-05-13 2025-11-20 (주) 업테라 분해 약물-항체 접합체용 plk1 분해 유도 화합물
CN119707950A (zh) * 2024-12-24 2025-03-28 无锡市南京大学锡山应用生物技术研究所 一种用于免疫蛋白靶向降解的嵌合体及其制备方法和应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1937671E (pt) * 2005-09-06 2010-03-12 Smithkline Beecham Corp Compostos de benzimidazole tiofeno como inibidores de plk
PT2125822E (pt) * 2006-12-21 2015-01-30 Nerviano Medical Sciences Srl Derivados de pirazol-quinazolina substituídos, processo para sua preparação e seu uso como inibidores da quinase
WO2008113711A1 (en) * 2007-03-22 2008-09-25 F. Hoffmann-La Roche Ag Substituted pyrimidodiazepines useful as plk1 inhibitors
WO2009042711A1 (en) * 2007-09-25 2009-04-02 Takeda Pharmaceutical Company Limited Polo-like kinase inhibitors
JP2011527667A (ja) 2008-06-18 2011-11-04 武田薬品工業株式会社 ハロ置換ピリミドジアゼピン
AR076784A1 (es) * 2009-05-26 2011-07-06 Nerviano Medical Sciences Srl Combinacion terapeutica que comprende un inhibidor de plk1 y un agente antineoplasico
CA2861066C (en) * 2012-01-12 2024-01-02 Yale University Compounds and methods for the enhanced degradation of targeted proteins and other polypeptides by an e3 ubiquitin ligase
AU2015247817C1 (en) 2014-04-14 2022-02-10 Arvinas Operations, Inc. Imide-based modulators of proteolysis and associated methods of use
US10730870B2 (en) 2015-03-18 2020-08-04 Arvinas Operations, Inc. Compounds and methods for the enhanced degradation of targeted proteins
WO2016197114A1 (en) 2015-06-05 2016-12-08 Arvinas, Inc. Tank-binding kinase-1 protacs and associated methods of use
AU2016349781A1 (en) * 2015-11-02 2018-05-10 Yale University Proteolysis targeting chimera compounds and methods of preparing and using same
US20170281784A1 (en) 2016-04-05 2017-10-05 Arvinas, Inc. Protein-protein interaction inducing technology
CN106543185B (zh) 2016-11-10 2017-12-15 吉林大学 一种靶向泛素化降解plk1和brd4蛋白的化合物及其应用
BR112019015484A2 (pt) * 2017-01-31 2020-04-28 Arvinas Operations Inc ligantes de cereblon e compostos bifuncionais compreendendo os mesmos
CN106977584B (zh) * 2017-04-19 2019-12-06 吉林大学 靶向泛素化降解plk1和brd4蛋白的化合物及其应用
CN109912655B (zh) 2017-12-13 2021-12-10 上海科技大学 Alk蛋白降解剂及其抗肿瘤应用
KR102127289B1 (ko) * 2018-09-18 2020-06-26 고려대학교 산학협력단 암 세포를 표적화하기 위한 plk 선택적 형광 프로브 화합물 및 이를 포함하는 plk 검출용 형광 센서
CN111018857B (zh) * 2018-10-09 2023-06-02 嘉兴优博生物技术有限公司 靶向蛋白酶降解平台(ted)
CN109879877B (zh) 2019-03-04 2021-08-10 吉林大学 一种可降解plk1和brd4蛋白的化合物及其应用
US20230158158A1 (en) * 2020-03-27 2023-05-25 Uppthera Pyrazolo quinazoline derivative compounds inducing selective degradation of plk1
EP4157849A4 (en) * 2021-08-10 2024-12-11 Uppthera, Inc. NOVEL PLK1 DEGRADATION-INDUCING COMPOUND

Similar Documents

Publication Publication Date Title
JP2023171659A5 (https=)
JP2024028453A5 (https=)
JP2021512059A5 (https=)
JP2021533135A5 (https=)
JP2006507265A5 (https=)
JP2021532162A5 (https=)
RU2017121906A (ru) Конъюгаты цистеамина и жирной кислоты и их применение в качестве активаторов аутофагии
JP2010504324A5 (https=)
JP2014528466A5 (https=)
RU2013152132A (ru) Борсодержащие малые молекулы в качестве противовоспалительных средств
JP2012528240A5 (https=)
JP2007524696A5 (https=)
JP2016053042A5 (https=)
RU2005134162A (ru) Новые соединения с антибактериальным действием
JP2014503574A5 (https=)
RU2009128591A (ru) Лиганды для визуализации иннервации сердца
TR201901246T4 (tr) Kimyasal bileşikler.
JP2006511490A5 (https=)
JP2020502116A5 (https=)
JP2015527355A5 (https=)
RU2009146124A (ru) Дигидрохиноновые и дигидронафтиридиновые ингибиторы киназы jnk
JPWO2022251502A5 (https=)
JP2006517201A5 (https=)
JP2020511450A5 (https=)
JP2024112835A5 (https=)